IP Library Patent Application 14021196
Patent Application
App. No. 14/021,196

Cell Preparations For Extemporaneous Use, Useful for Healing and Rejuvenation In Vivo

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/021,196
Abstract

The present invention relates to new plasma or new platelet-rich plasma preparations, new cell dissociation methods, new cell associations or compositions, a method of preparation thereof, a use thereof, devices for the preparation thereof and preparations containing such a platelet-rich plasma preparation and cell associations or compositions. Specifically, the invention provides plasma or platelet-rich plasma alone or in cell combinasons preparations for use in tissue regeneration and bone regeneration and pain reduction.

Claims (18)

1 . An isolated cell composition comprising:

a) plasma;

b) platelets at a concentration of at least 300×10 9 cells/L;

c) white blood cells at a concentration of at least 7.0×10 9 cells/L; and

d) fibrinogen at a concentration of at least 3 mg/L;

and wherein the erythrocyte concentration is less than 0.6×10 12 cells/L.

2 . An implantable device for use in tissue regeneration therapy comprising:

a) a permeable core comprising a cell composition comprising:

i) plasma;

ii) platelets at a concentration of at least 300×10 9 cells/L;

iii) white blood cells at a concentration of at least 7.0×10 9 cells/L;

iv) fibrinogen at a concentration of at least 3 mg/L; and

v) a cell extract where cells are selected from dermal cells, keratinocytes, fibroblasts, melanocytes and Langheran's cells; fat cells; bone marrow cells; muscle cells; osteoblasts; chondrocytes; periosteal membrane cells; corneal cells; umbilical cord cells; Schwann cells, tendon cells and pancreas islet cells, wherein cells are at a concentration of about 10 5 to about 10 6 cells/L and wherein the erythrocyte concentration of said cell composition is less than 0.6×10 12 cells/L; and

b) an external jacket surrounding said core, said jacket comprising a biocompatible material or a bioresorbable material.

3 . A device for the preparation of a platelet concentrate from whole blood comprising a separator tube wherein the separator tube is selected from:

a glass separator tube containing a polyester-based thixotropic gel and a buffered sodium citrate solution at 0.10 M; and

a polyethylene terephthalate separator tube containing a highly thixotropic gel formed by a polymer mixture and an anhydrous sodium citrate at 3.5 mg/mL;

characterised in that the device has an inlet for introducing said whole blood, is held in a vacuum intended to aspirate the whole blood sample, is sterile, has a usable vacuum of or about 8 to about 10 mL and is suitable for undergoing centrifugation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2018
From: TURZI, ANTOINE
To: REGENLAB USA LLC
Reel/Frame 045490/0245 →